Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meike E W Logtenberg

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Immunity|May 21, 2020
The CD47-SIRPα Immune CheckpointMeike E W Logtenberg, Ferenc A Scheeren, Ton N Schumacher
Scientific Reports|July 27, 2019
Delta-like 1-mediated cis-inhibition of Jagged1/2 signalling inhibits differentiation of human epidermal cells in cultureVictor A Negri, Meike E W Logtenberg, Lisa M Renz, et al.
Oncoimmunology|March 21, 2022
QPCTL regulates macrophage and monocyte abundance and inflammatory signatures in the tumor microenvironmentKaspar Bresser, Meike E W Logtenberg, Mireille Toebes, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 30, 2024
ITPK1 Sensitizes Tumor Cells to IgA-dependent Neutrophil Killing In VivoConnor A Richterich, Meike E W Logtenberg, Marco J H Jansen, et al.
Nature|August 17, 2017
Identification of CMTM6 and CMTM4 as PD-L1 protein regulatorsRiccardo Mezzadra, Chong Sun, Lucas T Jae, et al.
Cell Reports. Medicine|February 22, 2023
An adverse tumor-protective effect of IDO1 inhibitionJuliana C N Kenski, Xinyao Huang, David W Vredevoogd, et al.
Nature Medicine|March 6, 2019
Glutaminyl cyclase is an enzymatic modifier of the CD47- SIRPα axis and a target for cancer immunotherapyMeike E W Logtenberg, J H Marco Jansen, Matthijs Raaben, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Immunity|May 21, 2020
The CD47-SIRPα Immune CheckpointMeike E W Logtenberg, Ferenc A Scheeren, Ton N Schumacher
Scientific Reports|July 27, 2019
Delta-like 1-mediated cis-inhibition of Jagged1/2 signalling inhibits differentiation of human epidermal cells in cultureVictor A Negri, Meike E W Logtenberg, Lisa M Renz, et al.
Oncoimmunology|March 21, 2022
QPCTL regulates macrophage and monocyte abundance and inflammatory signatures in the tumor microenvironmentKaspar Bresser, Meike E W Logtenberg, Mireille Toebes, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 30, 2024
ITPK1 Sensitizes Tumor Cells to IgA-dependent Neutrophil Killing In VivoConnor A Richterich, Meike E W Logtenberg, Marco J H Jansen, et al.
Nature|August 17, 2017
Identification of CMTM6 and CMTM4 as PD-L1 protein regulatorsRiccardo Mezzadra, Chong Sun, Lucas T Jae, et al.
Cell Reports. Medicine|February 22, 2023
An adverse tumor-protective effect of IDO1 inhibitionJuliana C N Kenski, Xinyao Huang, David W Vredevoogd, et al.
Nature Medicine|March 6, 2019
Glutaminyl cyclase is an enzymatic modifier of the CD47- SIRPα axis and a target for cancer immunotherapyMeike E W Logtenberg, J H Marco Jansen, Matthijs Raaben, et al.
Pageof 1